Episode

248. Are GLP-1s a Catalyst or a Crutch?

Podcast
Make Fit Simple
Published
Aug 20, 2025
Duration seconds
2006
Processing state
not_requested
Canonical source
https://verifi.podscribe.com/rss/p/www.buzzsprout.com/1778813/episodes/17686292-248-are-glp-1s-a-catalyst-or-a-crutch.mp3
Audio
https://verifi.podscribe.com/rss/p/www.buzzsprout.com/1778813/episodes/17686292-248-are-glp-1s-a-catalyst-or-a-crutch.mp3
JSON
/v1/public/podcasts/make-fit-simple-1367946/episodes/248-are-glp-1s-a-catalyst-or-a-crutch
Markdown
/podcast/make-fit-simple-1367946/248-are-glp-1s-a-catalyst-or-a-crutch.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/make-fit-simple-1367946/episodes/248-are-glp-1s-a-catalyst-or-a-crutch/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/make-fit-simple-1367946/248-are-glp-1s-a-catalyst-or-a-crutch.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Andrea dives into a topic she’s been closely following for a long time: GLP-1 medications like Ozempic, Wegovy, and Mounjaro. As a personal trainer and nutrition coach, she breaks down what GLP-1s are, how they work, their benefits and side effects, and most importantly, whether they serve as a catalyst or a crutch in someone’s health journey. Drawing from real-life scenarios, client experiences, and extensive research, Andrea brings a clear, thoughtful perspective to a complex and often cont...